Who Buys Combiflam from India — 68 Importers Behind a $24.3K Market

The importation of Combiflam from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.

Distributors: Entities like ODHAV MULTI INDUSTRIES SA in Guinea and VMK MEDICAL ENTERPRISES in Seychelles function as intermediaries, procuring large quantities of Combiflam to supply local pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by bulk orders to achieve economies of scale, with a focus on maintaining consistent inventory levels to meet market demand.

Hospital Groups: Organizations such as HAROON TIMOR ZAHIRI LIMITED in Afghanistan represent hospital groups that import Combiflam directly for in-house use. Their procurement is driven by patient needs and formulary requirements, leading to regular, sizable orders to ensure uninterrupted patient care.

Retail Chains: While specific retail chains are not identified among the top buyers, this segment typically includes pharmacy chains that import Combiflam to stock their outlets. Their purchasing behavior involves moderate-sized, frequent orders aligned with consumer demand and inventory turnover rates.

Government Procurement: This segment encompasses national health departments and international organizations like UNICEF and the Global Fund, which procure Combiflam for public health initiatives. Their buying patterns are characterized by large-volume purchases through formal tender processes, often with stringent quality and compliance requirements.

Re-exporters: Some buyers may act as re-exporters, importing Combiflam with the intent to distribute it to neighboring countries. This segment's purchasing behavior includes bulk orders, with a focus on market demand in target export regions.

Contract Manufacturers: Entities in this category import Combiflam as a component for further manufacturing or repackaging. Their order patterns are typically large and consistent, aligned with production schedules and contractual obligations.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

Seychelles:

1. Drug Regulatory Authority Name: Ministry of Health

2. Import Registration Process for Combiflam: Importers must apply for an import license from the Ministry of Health through the Import and Export Unit of the Trade Division within the Ministry of Finance, National Planning, and Trade. This unit acts as a one-stop shop for processing applications and facilitating the licensing process.

3. Estimated Timeline for Registration: Specific timelines are not detailed in the available sources.

4. Import Tariff/Duty for HS 30049063: Medicaments under HS code 300490 are subject to a 0% customs duty in Seychelles.

Guinea:

1. Drug Regulatory Authority Name: Direction Nationale de la Pharmacie et du Médicament (DNPM)

2. Import Registration Process for Combiflam: Importers are required to submit a dossier to the DNPM, including product information, manufacturing details, and quality certifications.

3. Estimated Timeline for Registration: The registration process typically takes several months, depending on the completeness of the application and the DNPM's review schedule.

4. Import Tariff/Duty for HS 30049063: Specific tariff information for Guinea is not available in the provided sources.

Afghanistan:

1. Drug Regulatory Authority Name: Afghanistan National Medicines and Health Products Regulatory Authority (ANMHPRA)

2. Import Registration Process for Combiflam: Importers must obtain a registration certificate from the ANMHPRA, which involves submitting detailed product documentation and compliance with national standards.

3. Estimated Timeline for Registration: The registration process can take several months, subject to the ANMHPRA's evaluation procedures.

4. Import Tariff/Duty for HS 30049063: Specific tariff information for Afghanistan is not available in the provided sources.

Cayman Islands:

1. Drug Regulatory Authority Name: Health Regulatory Services (HRS)

2. Import Registration Process for Combiflam: Importers are required to obtain approval from the HRS, which includes submitting product details and ensuring compliance with local regulations.

3. Estimated Timeline for Registration: The registration timeline varies based on the completeness of the application and the HRS's review process.

4. Import Tariff/Duty for HS 30049063: Specific tariff information for the Cayman Islands is not available in the provided sources.

Pakistan:

1. Drug Regulatory Authority Name: Drug Regulatory Authority of Pakistan (DRAP)

2. Import Registration Process for Combiflam: Importers must have a valid Drug Import License (DIL) issued by DRAP. Applications are submitted online through the DRAP portal, accompanied by the necessary documentation. (dra.gov.pk)

3. Estimated Timeline for Registration: The processing time for a Drug Import License is approximately 5 days. (dra.gov.pk)

4. Import Tariff/Duty for HS 30049063: Specific tariff information for Pakistan is not available in the provided sources.

The demand for Combiflam in importing countries is influenced by several factors:

1. Disease Prevalence: Combiflam, being an analgesic and antipyretic, is widely used to manage pain and fever associated with various conditions. High incidences of infectious diseases and chronic conditions in regions like Guinea and Afghanistan contribute to increased demand.

2. Government Healthcare Programs: National health initiatives aiming to improve access to essential medicines often include analgesics like Combiflam. For instance, Pakistan's healthcare programs focus on providing affordable medications to the population, thereby driving imports.

3. Universal Health Coverage Expansion: Countries expanding their health coverage, such as Seychelles, are increasing the availability of essential medicines, leading to higher imports of products like Combiflam.

4. WHO Essential Medicines List Procurement: Combiflam's inclusion in the WHO Essential Medicines List encourages its procurement by governments and international organizations, ensuring its availability in public health systems.

5. Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of pharmaceuticals. Entities like ODHAV MULTI INDUSTRIES SA and VMK MEDICAL ENTERPRISES participate in these tenders, leading to substantial orders and consistent demand.

With 68 buyers across 21 countries, the market for Combiflam demonstrates a robust and diverse demand, presenting significant opportunities for suppliers to cater to various healthcare needs globally.

The importation of Combiflam from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.

Distributors: Entities like ODHAV MULTI INDUSTRIES SA in Guinea and VMK MEDICAL ENTERPRISES in Seychelles function as intermediaries, procuring large quantities of Combiflam to supply local pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by bulk orders to achieve economies of scale, with a focus on maintaining consistent inventory levels to meet market demand.

Hospital Groups: Organizations such as HAROON TIMOR ZAHIRI LIMITED in Afghanistan represent hospital groups that import Combiflam directly for in-house use. Their procurement is driven by patient needs and formulary requirements, leading to regular, sizable orders to ensure uninterrupted patient care.

Retail Chains: While specific retail chains are not identified among the top buyers, this segment typically includes pharmacy chains that import Combiflam to stock their outlets. Their purchasing behavior involves moderate-sized, frequent orders aligned with consumer demand and inventory turnover rates.

Government Procurement: This segment encompasses national health departments and international organizations like UNICEF and the Global Fund, which procure Combiflam for public health initiatives. Their buying patterns are characterized by large-volume purchases through formal tender processes, often with stringent quality and compliance requirements.

Re-exporters: Some buyers may act as re-exporters, importing Combiflam with the intent to distribute it to neighboring countries. This segment's purchasing behavior includes bulk orders, with a focus on market demand in target export regions.

Contract Manufacturers: Entities in this category import Combiflam as a component for further manufacturing or repackaging. Their order patterns are typically large and consistent, aligned with production schedules and contractual obligations.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

Seychelles:

1. Drug Regulatory Authority Name: Ministry of Health

2. Import Registration Process for Combiflam: Importers must apply for an import license from the Ministry of Health through the Import and Export Unit of the Trade Division within the Ministry of Finance, National Planning, and Trade. This unit acts as a one-stop shop for processing applications and facilitating the licensing process.

3. Estimated Timeline for Registration: Specific timelines are not detailed in the available sources.

4. Import Tariff/Duty for HS 30049063: Medicaments under HS code 300490 are subject to a 0% customs duty in Seychelles.

Guinea:

1. Drug Regulatory Authority Name: Direction Nationale de la Pharmacie et du Médicament (DNPM)

2. Import Registration Process for Combiflam: Importers are required to submit a dossier to the DNPM, including product information, manufacturing details, and quality certifications.

3. Estimated Timeline for Registration: The registration process typically takes several months, depending on the completeness of the application and the DNPM's review schedule.

4. Import Tariff/Duty for HS 30049063: Specific tariff information for Guinea is not available in the provided sources.

Afghanistan:

1. Drug Regulatory Authority Name: Afghanistan National Medicines and Health Products Regulatory Authority (ANMHPRA)

2. Import Registration Process for Combiflam: Importers must obtain a registration certificate from the ANMHPRA, which involves submitting detailed product documentation and compliance with national standards.

3. Estimated Timeline for Registration: The registration process can take several months, subject to the ANMHPRA's evaluation procedures.

4. Import Tariff/Duty for HS 30049063: Specific tariff information for Afghanistan is not available in the provided sources.

Cayman Islands:

1. Drug Regulatory Authority Name: Health Regulatory Services (HRS)

2. Import Registration Process for Combiflam: Importers are required to obtain approval from the HRS, which includes submitting product details and ensuring compliance with local regulations.

3. Estimated Timeline for Registration: The registration timeline varies based on the completeness of the application and the HRS's review process.

4. Import Tariff/Duty for HS 30049063: Specific tariff information for the Cayman Islands is not available in the provided sources.

Pakistan:

1. Drug Regulatory Authority Name: Drug Regulatory Authority of Pakistan (DRAP)

2. Import Registration Process for Combiflam: Importers must have a valid Drug Import License (DIL) issued by DRAP. Applications are submitted online through the DRAP portal, accompanied by the necessary documentation. (dra.gov.pk)

3. Estimated Timeline for Registration: The processing time for a Drug Import License is approximately 5 days. (dra.gov.pk)

4. Import Tariff/Duty for HS 30049063: Specific tariff information for Pakistan is not available in the provided sources.

The demand for Combiflam in importing countries is influenced by several factors:

1. Disease Prevalence: Combiflam, being an analgesic and antipyretic, is widely used to manage pain and fever associated with various conditions. High incidences of infectious diseases and chronic conditions in regions like Guinea and Afghanistan contribute to increased demand.

2. Government Healthcare Programs: National health initiatives aiming to improve access to essential medicines often include analgesics like Combiflam. For instance, Pakistan's healthcare programs focus on providing affordable medications to the population, thereby driving imports.

3. Universal Health Coverage Expansion: Countries expanding their health coverage, such as Seychelles, are increasing the availability of essential medicines, leading to higher imports of products like Combiflam.

4. WHO Essential Medicines List Procurement: Combiflam's inclusion in the WHO Essential Medicines List encourages its procurement by governments and international organizations, ensuring its availability in public health systems.

5. Tender-Based Purchasing: Many countries utilize tender systems for bulk purchasing of pharmaceuticals. Entities like ODHAV MULTI INDUSTRIES SA and VMK MEDICAL ENTERPRISES participate in these tenders, leading to substantial orders and consistent demand.

With 68 buyers across 21 countries, the market for Combiflam demonstrates a robust and diverse demand, presenting significant opportunities for suppliers to cater to various healthcare needs globally.